{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T03:22:30Z","timestamp":1780543350083,"version":"3.54.1"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01-HL054926"],"award-info":[{"award-number":["R01-HL054926"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-08203-8","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T18:31:20Z","timestamp":1748370680000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Proteomic surveys of the mouse heart unveil cardiovascular responses to nitric oxide\/cGMP signaling deficiencies"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0894-4770","authenticated-orcid":false,"given":"Ipsita","family":"Mohanty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Fazelinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Raimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Spruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Symeonidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Tenopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4535-1632","authenticated-orcid":false,"given":"Fumito","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Shimokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutsui","family":"Masato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paschalis-Thomas","family":"Doulias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8284-5098","authenticated-orcid":false,"given":"Harry","family":"Ischiropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"key":"8203_CR1","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1001\/jama.1996.03540140074032","volume":"276","author":"RF Furchgott","year":"1996","unstructured":"Furchgott, R. F. The 1996 Albert Lasker Medical Research Awards. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide. JAMA 276, 1186\u20131188 (1996).","journal-title":"JAMA"},{"key":"8203_CR2","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1056\/NEJMsa063904","volume":"355","author":"F Murad","year":"2006","unstructured":"Murad, F. Shattuck Lecture. Nitric oxide and cyclic GMP in cell signaling and drug development. N. Engl. J. Med. 355, 2003\u20132011 (2006).","journal-title":"N. Engl. J. Med."},{"key":"8203_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1023\/A:1020150124721","volume":"19","author":"LJ Ignarro","year":"1999","unstructured":"Ignarro, L. J. Nitric oxide: a unique endogenous signaling molecule in vascular biology. Biosci. Rep. 19, 51\u201371 (1999).","journal-title":"Biosci. Rep."},{"key":"8203_CR4","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1038\/sj.bjp.0706458","volume":"147","author":"S Moncada","year":"2006","unstructured":"Moncada, S. & Higgs, E. A. The discovery of nitric oxide and its role in vascular biology. Br. J. Pharmacol. 147, S193\u2013S201 (2006).","journal-title":"Br. J. Pharmacol."},{"key":"8203_CR5","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrd4623","volume":"4","author":"JO Lundberg","year":"2015","unstructured":"Lundberg, J. O., Gladwin, M. T. & Weitzberg, E. Strategies to increase nitric oxide signaling in cardiovascular disease. Nat. Rev. Drug Discov. 4, 623\u2013641 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"key":"8203_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.tem.2009.03.005","volume":"20","author":"PL Huang","year":"2009","unstructured":"Huang, P. L. eNOS, metabolic syndrome, and cardiovascular disease. Trends Endocrinol. Metab. 20, 295\u2013302 (2009).","journal-title":"Trends Endocrinol. Metab."},{"key":"8203_CR7","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1161\/01.CIR.88.6.2510","volume":"88","author":"MT Johnstone","year":"1993","unstructured":"Johnstone, M. T. et al. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 88, 2510\u20132516 (1993).","journal-title":"Circulation"},{"key":"8203_CR8","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1161\/01.CIR.93.7.1331","volume":"93","author":"JR Petrie","year":"1996","unstructured":"Petrie, J. R., Ueda, S., Webb, D. J., Elliott, H. L. & Connell, J. M. Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease. Circulation 93, 1331\u20131333 (1996).","journal-title":"Circulation"},{"key":"8203_CR9","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1161\/01.CIR.97.25.2494","volume":"97","author":"BS Oemar","year":"1998","unstructured":"Oemar, B. S. et al. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 97, 2494\u20132498 (1998).","journal-title":"Circulation"},{"key":"8203_CR10","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.2337\/diabetes.52.5.1270","volume":"52","author":"LD Monti","year":"2003","unstructured":"Monti, L. D. et al. Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes 52, 1270\u20131275 (2003).","journal-title":"Diabetes"},{"key":"8203_CR11","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1097\/HJH.0b013e3283487806","volume":"29","author":"M Siervo","year":"2011","unstructured":"Siervo, M., Jackson, S. J. & Bluck, L. J. In-vivo nitric oxide synthesis is reduced in obese patients with metabolic syndrome: application of a novel stable isotopic method. J. Hypertens. 29, 1515\u20131527 (2011).","journal-title":"J. Hypertens."},{"key":"8203_CR12","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/nature12722","volume":"504","author":"J Erdmann","year":"2013","unstructured":"Erdmann, J. et al. Dysfunctional nitric oxide signalling increases risk of myocardial infarction. Nature 504, 432\u2013436 (2013).","journal-title":"Nature"},{"key":"8203_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s11010-012-1456-y","volume":"372","author":"JA Miranda","year":"2013","unstructured":"Miranda, J. A., Belo, V. A., Souza-Costa, D. C., Lanna, C. M. & Tanus-Santos, J. E. eNOS polymorphism associated with metabolic syndrome in children and adolescents. Mol. Cell Biochem. 372, 155\u2013160 (2013).","journal-title":"Mol. Cell Biochem."},{"key":"8203_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1161\/CIRCULATIONAHA.117.028021","volume":"137","author":"CA Emdin","year":"2018","unstructured":"Emdin, C. A. et al. Phenotypic consequences of a genetic predisposition to enhanced nitric oxide signaling. Circulation 137, 222\u2013232 (2018).","journal-title":"Circulation"},{"key":"8203_CR15","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.pharmthera.2009.02.009","volume":"122","author":"EJ Tsai","year":"2009","unstructured":"Tsai, E. J. & Kass, D. A. Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics. Pharmacol. Ther. 122, 216\u2013238 (2009).","journal-title":"Pharmacol. Ther."},{"key":"8203_CR16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1124\/pr.110.002907","volume":"62","author":"SH Francis","year":"2010","unstructured":"Francis, S. H., Busch, J. A. & Corbin, J. D. Cyclic GMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol. Rev. 62, 525\u2013563 (2010).","journal-title":"Pharmacol. Rev."},{"key":"8203_CR17","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1161\/CIRCRESAHA.110.233239","volume":"107","author":"SH Francis","year":"2010","unstructured":"Francis, S. H. The role of cGMP-dependent protein kinase in controlling cardiomyocyte cGMP. Circ. Res. 107, 1164\u20131166 (2010).","journal-title":"Circ. Res."},{"key":"8203_CR18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/cvr\/cvw107","volume":"111","author":"PP Rainer","year":"2016","unstructured":"Rainer, P. P. & Kass, D. A. Old dog, new tricks: novel cardiac targets and stress regulation by protein kinase G. Cardiovasc. Res. 111, 154\u2013162 (2016).","journal-title":"Cardiovasc. Res."},{"key":"8203_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00395-018-0690-1","volume":"113","author":"F Hofmann","year":"2018","unstructured":"Hofmann, F. A concise discussion of the regulatory role of cGMP kinase I in cardiac physiology and pathology. Basic Res. Cardiol. 113, 31 (2018).","journal-title":"Basic Res. Cardiol."},{"key":"8203_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cbpa.2010.10.012","volume":"15","author":"D Seth","year":"2011","unstructured":"Seth, D. & Stamler, J. S. The SNO-proteome: causation and classifications. Curr. Opin. Chem. Biol. 15, 129\u2013136 (2011).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"8203_CR21","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.cbpa.2012.10.016","volume":"16","author":"BC Smith","year":"2012","unstructured":"Smith, B. C. & Marletta, M. A. Mechanisms of S-nitrosothiol formation and selectivity in nitric oxide signaling. Curr. Opin. Chem. Biol. 16, 498\u2013506 (2012).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"8203_CR22","doi-asserted-by":"publisher","first-page":"26473","DOI":"10.1074\/jbc.R113.460261","volume":"288","author":"N Gould","year":"2013","unstructured":"Gould, N., Doulias, P. T., Tenopoulou, M., Raju, K. & Ischiropoulos, H. Regulation of protein function and signaling by reversible cysteine S-nitrosylation. J. Biol. Chem. 288, 26473\u201326479 (2013).","journal-title":"J. Biol. Chem."},{"key":"8203_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.freeradbiomed.2012.09.005","volume":"54","author":"J Sun","year":"2013","unstructured":"Sun, J. et al. Essential role of nitric oxide in acute ischemic preconditioning: S-nitros(yl)ation versus sGC\/cGMP\/PKG signaling? Free Radic. Biol. Med. 54, 105\u2013112 (2013).","journal-title":"Free Radic. Biol. Med."},{"key":"8203_CR24","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1161\/CIRCRESAHA.115.307157","volume":"117","author":"T Irie","year":"2015","unstructured":"Irie, T. et al. S-Nitrosylation of Calcium-Handling Proteins in Cardiac Adrenergic Signaling and Hypertrophy. Circ. Res. 117, 793\u2013803 (2015).","journal-title":"Circ. Res."},{"key":"8203_CR25","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1161\/CIRCRESAHA.118.312789","volume":"122","author":"SB Wang","year":"2018","unstructured":"Wang, S. B. et al. Protein S-nitrosylation controls glycogen synthase kinase 3\u03b2 function independent of its phosphorylation state. Circ. Res. 122, 1517\u20131531 (2018).","journal-title":"Circ. Res."},{"key":"8203_CR26","doi-asserted-by":"publisher","first-page":"E10763","DOI":"10.1073\/pnas.1712623114","volume":"114","author":"HS Chung","year":"2017","unstructured":"Chung, H. S. et al. Transient receptor potential channel 6 regulates abnormal cardiac S-nitrosylation in Duchenne muscular dystrophy. Proc. Natl. Acad. Sci. USA 114, E10763\u2013E10771 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"8203_CR27","doi-asserted-by":"publisher","first-page":"rs1-7","DOI":"10.1126\/scisignal.2003252","volume":"6","author":"P-T Doulias","year":"2013","unstructured":"Doulias, P.-T., Tenopoulou, M., Greene, J. L., Raju, K. & Ischiropoulos, H. Nitric oxide regulates mitochondrial fatty acid metabolism through reversible protein S-nitrosylation. Sci. Signal. 6, rs1-7 (2013).","journal-title":"Sci. Signal."},{"key":"8203_CR28","doi-asserted-by":"publisher","first-page":"6282","DOI":"10.1074\/jbc.M117.817700","volume":"293","author":"JJ Bruegger","year":"2018","unstructured":"Bruegger, J. J., Smith, B. C., Wynia-Smith, S. L. & Marletta, M. A. Comparative and integrative metabolomics reveal that Snitrosation inhibits physiologically relevant metabolic enzymes. J. Biol. Chem. 293, 6282\u20136296 (2018).","journal-title":"J. Biol. Chem."},{"key":"8203_CR29","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41586-018-0749-z","volume":"565","author":"HL Zhou","year":"2019","unstructured":"Zhou, H. L. et al. Metabolic reprogramming by the S-nitroso-CoA reductase system protects against kidney injury. Nature 565, 96\u2013100 (2019).","journal-title":"Nature"},{"key":"8203_CR30","doi-asserted-by":"publisher","first-page":"102153","DOI":"10.1016\/j.redox.2021.102153","volume":"47","author":"B Lau","year":"2021","unstructured":"Lau, B. et al. Endogenous Snitrosocysteine proteomic inventories identify a core of proteins in heart metabolic pathways. Redox. Biol. 47, 102153 (2021).","journal-title":"Redox. Biol."},{"key":"8203_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/377239a0","volume":"377","author":"PL Huang","year":"1995","unstructured":"Huang, P. L. et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377, 239\u2013242 (1995).","journal-title":"Nature"},{"key":"8203_CR32","doi-asserted-by":"publisher","first-page":"13176","DOI":"10.1073\/pnas.93.23.13176","volume":"93","author":"EG Shesely","year":"1996","unstructured":"Shesely, E. G. et al. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 93, 13176\u201313181 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"8203_CR33","doi-asserted-by":"publisher","first-page":"684","DOI":"10.2337\/diabetes.49.5.684","volume":"49","author":"RR Shankar","year":"2000","unstructured":"Shankar, R. R., Wu, Y., Shen, H. Q., Zhu, J. S. & Baron, A. D. Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes 49, 684\u2013687 (2000).","journal-title":"Diabetes"},{"key":"8203_CR34","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/416337a","volume":"416","author":"LA Barouch","year":"2002","unstructured":"Barouch, L. A. et al. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416, 337\u2013339 (2002).","journal-title":"Nature"},{"key":"8203_CR35","doi-asserted-by":"publisher","first-page":"10688","DOI":"10.1073\/pnas.92.23.10688","volume":"92","author":"VE Laubach","year":"1995","unstructured":"Laubach, V. E., Shesely, E. G., Smithies, O. & Sherman, P. A. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc. Natl. Acad. Sci. USA 92, 10688\u201310692 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"8203_CR36","doi-asserted-by":"publisher","first-page":"11507","DOI":"10.1073\/pnas.96.20.11507","volume":"96","author":"Y Guo","year":"1999","unstructured":"Guo, Y. et al. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc. Natl. Acad. Sci. USA 96, 11507\u201311512 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"8203_CR37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1254\/jphs.CPJ06015X","volume":"102","author":"M Tsutsui","year":"2006","unstructured":"Tsutsui, M., Shimokawa, H., Morishita, T., Nakashima, Y. & Yanagihara, N. Development of genetically engineered mice lacking all three nitric oxide synthases. J. Pharmacol. Sci. 102, 147\u2013154 (2006).","journal-title":"J. Pharmacol. Sci."},{"key":"8203_CR38","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1253\/circj.CJ-10-0277","volume":"74","author":"K Shibata","year":"2010","unstructured":"Shibata, K. et al. Spontaneous development of left ventricular hypertrophy and diastolic dysfunction in mice lacking all nitric oxide synthases. Circ. J. 74, 2681\u20132692 (2010).","journal-title":"Circ. J."},{"key":"8203_CR39","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jphs.2014.10.002","volume":"127","author":"M Tsutsui","year":"2015","unstructured":"Tsutsui, M. et al. Significance of nitric oxide synthases: Lessons from triple nitric oxide synthases null mice. J. Pharm. Sci. 127, 42\u201352 (2015).","journal-title":"J. Pharm. Sci."},{"key":"8203_CR40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/cvr\/cvn068","volume":"79","author":"ES Buys","year":"2008","unstructured":"Buys, E. S. et al. Gender-specific hypertension and responsiveness to nitric oxide in sGC{alpha}1 knockout mice. Cardiovasc. Res. 79, 179\u2013186 (2008).","journal-title":"Cardiovasc. Res."},{"key":"8203_CR41","doi-asserted-by":"publisher","first-page":"H157","DOI":"10.1152\/ajpheart.01273.2010","volume":"301","author":"SM Cawley","year":"2011","unstructured":"Cawley, S. M. et al. sGC{alpha}1 mediates the negative inotropic effects of NO in cardiac myocytes independent of changes in calcium handling. Am. J. Physiol. Heart Circ. Physiol. 301, H157\u2013H163 (2011).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"8203_CR42","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1172\/JCI60119","volume":"122","author":"ES Buys","year":"2012","unstructured":"Buys, E. S. et al. Genetic modifiers of hypertension in soluble guanylate cyclase \u03b11-deficient mice. J. Clin. Invest. 122, 2316\u20132325 (2012).","journal-title":"J. Clin. Invest."},{"key":"8203_CR43","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.chembiol.2015.06.010","volume":"22","author":"NS Gould","year":"2015","unstructured":"Gould, N. S. et al. Site-Specific Proteomic Mapping Identifies Selectively Modified Regulatory Cysteine Residues in Functionally Distinct Protein Networks. Chem. Biol. 22, 965\u2013975 (2015).","journal-title":"Chem. Biol."},{"key":"8203_CR44","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1002\/pmic.201400441","volume":"15","author":"M Wang","year":"2015","unstructured":"Wang, M., Herrmann, C. J., Simonovic, M., Szklarczyk, D. & von Mering, C. Version 4.0 of PaxDb: Protein abundance data, integrated across model organisms, tissues, and cell-lines. Proteomics 15, 3163\u20133168 (2015).","journal-title":"Proteomics"},{"key":"8203_CR45","doi-asserted-by":"publisher","first-page":"D480","DOI":"10.1093\/nar\/gkaa1100","volume":"49","author":"The UniProt Consortium","year":"2021","unstructured":"The UniProt Consortium. UniProt: the universal protein knowledgebase. Nucleic Acids Res. 49, D480\u2013D489 (2021).","journal-title":"Nucleic Acids Res."},{"key":"8203_CR46","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1172\/JCI2843","volume":"102","author":"P Jumrussirikul","year":"1998","unstructured":"Jumrussirikul, P. et al. Interaction between neuronal nitric oxide synthase and inhibitory G protein activity in heart rate regulation in conscious mice. J. Clin. Invest. 102, 1279\u20131285 (1998).","journal-title":"J. Clin. Invest."},{"key":"8203_CR47","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1161\/01.RES.0000064585.95749.6D","volume":"92","author":"CE Sears","year":"2003","unstructured":"Sears, C. E. et al. Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling. Circ. Res. 92, e52\u2013e59 (2003).","journal-title":"Circ. Res."},{"key":"8203_CR48","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1161\/01.CIR.104.3.342","volume":"104","author":"H Duplain","year":"2001","unstructured":"Duplain, H. et al. Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 104, 342\u2013345 (2001).","journal-title":"Circulation"},{"key":"8203_CR49","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.2337\/db06-1228","volume":"56","author":"E Le Gouill","year":"2007","unstructured":"Le Gouill, E. et al. Endothelial nitric oxide synthase (eNOS) knockout mice have defective mitochondrial beta-oxidation. Diabetes 56, 2690\u20132696 (2007).","journal-title":"Diabetes"},{"key":"8203_CR50","doi-asserted-by":"publisher","first-page":"pii: 122156","DOI":"10.1172\/jci.insight.122156","volume":"3","author":"M Tenopoulou","year":"2018","unstructured":"Tenopoulou, M. et al. Oral nitrite restores age-dependent phenotypes in eNOS null mice. JCI Insight 3, pii: 122156 (2018).","journal-title":"JCI Insight"},{"key":"8203_CR51","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"8203_CR52","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1074\/mcp.TIR120.002155","volume":"19","author":"J Griss","year":"2020","unstructured":"Griss, J. et al. Reactome GSA-Efficient Multi-Omics Comparative Pathway Analysis. Mol. Cell Proteomics. 19, 2115\u20132125 (2020).","journal-title":"Mol. Cell Proteomics."},{"key":"8203_CR53","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1073\/pnas.95.6.2979","volume":"95","author":"WC Claycomb","year":"1998","unstructured":"Claycomb, W. C. et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc. Natl. Acad. Sci. USA. 95, 2979\u20132984 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"8203_CR54","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0006-291X(92)92378-B","volume":"188","author":"JL Duff","year":"1992","unstructured":"Duff, J. L., Berk, B. C. & Corson, M. A. Angiotensin II stimulates the pp44 and pp42 mitogen-activated protein kinases in cultured rat aortic smooth muscle cells. Biochem Biophys. Res. Commun. 188, 257\u2013264 (1992).","journal-title":"Biochem Biophys. Res. Commun."},{"key":"8203_CR55","first-page":"I-281","volume":"94","author":"JA Suero","year":"1996","unstructured":"Suero, J. A. & Berk, B. C. Angiotensin II prevents apoptosis by differential effects on mitogen activated protein kinases (MAPK): JNK, p38, and ERK1\/2. Circulation 94, I-281 (1996).","journal-title":"Circulation"},{"key":"8203_CR56","doi-asserted-by":"publisher","first-page":"33592","DOI":"10.1074\/jbc.271.52.33592","volume":"271","author":"Y Zou","year":"1996","unstructured":"Zou, Y. et al. Protein kinase C, but not tyrosine kinases or Ras, plays a critical role in angiotensin II-induced activation of Raf-1 kinase and extracellular signal-regulated protein kinases in cardiac myocytes. J. Biol. Chem. 271, 33592\u201333597 (1996).","journal-title":"J. Biol. Chem."},{"key":"8203_CR57","doi-asserted-by":"publisher","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","volume":"292","author":"PK Mehta","year":"2007","unstructured":"Mehta, P. K. & Griendling, K. K. Angiotensin II cell signaling: Physiological and pathological effects in the cardiovascular system. Am. J. Physiol. Physiol. 292, C82\u2013C97 (2007).","journal-title":"Am. J. Physiol. Physiol."},{"key":"8203_CR58","doi-asserted-by":"publisher","first-page":"115837","DOI":"10.1016\/j.bcp.2023.115837","volume":"217","author":"M Gekle","year":"2023","unstructured":"Gekle, M., Dubourg, V., Schwerdt, G., Benndorf, R. A. & Schreier, B. The role of EGFR in vascular AT1R signaling: From cellular mechanisms to systemic relevance. Biochem. Pharmacol. 217, 115837 (2023).","journal-title":"Biochem. Pharmacol."},{"key":"8203_CR59","doi-asserted-by":"publisher","first-page":"H654","DOI":"10.1152\/ajpheart.00367.2009","volume":"297","author":"ES Buys","year":"2009","unstructured":"Buys, E. S. et al. sGC\u03b11\u03b21 attenuates cardiac dysfunction and mortality in murine inflammatory shock models. Am. J. Physiol. Heart Circ. Physiol. 297, H654\u2013H663 (2009).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"8203_CR60","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/CCM.0b013e318192face","volume":"37","author":"T Nishida","year":"2009","unstructured":"Nishida, T. et al. Protective effects of nitric oxide synthase 3 and soluble guanylate cyclase on the outcome of cardiac arrest and cardiopulmonary resuscitation in mice. Crit. Care. Med. 37, 256\u2013262 (2009).","journal-title":"Crit. Care. Med."},{"key":"8203_CR61","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1161\/CIRCULATIONAHA.107.742692","volume":"117","author":"S Nakata","year":"2008","unstructured":"Nakata, S. et al. Spontaneous myocardial infarction in mice lacking all nitric oxide synthase isoforms. Circulation 117, 2211\u20132223 (2008).","journal-title":"Circulation"},{"key":"8203_CR62","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/cvr\/cvq092","volume":"87","author":"Y Yatera","year":"2010","unstructured":"Yatera, Y. et al. Severe dyslipidaemia, atherosclerosis, and sudden cardiac death in mice lacking all NO synthases fed a high-fat diet. Cardiovasc. Res. 87, 675\u2013682 (2010).","journal-title":"Cardiovasc. Res."},{"key":"8203_CR63","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1172\/JCI27657","volume":"116","author":"E Mergia","year":"2006","unstructured":"Mergia, E., Friebe, A., Dangel, O., Russwurm, M. & Koesling, D. Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system. J. Clin. Invest. 116, 1731\u20131737 (2006).","journal-title":"J. Clin. Invest."},{"key":"8203_CR64","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1161\/CIRCRESAHA.110.226712","volume":"107","author":"LR Castro","year":"2010","unstructured":"Castro, L. R., Schittl, J. & Fischmeister, R. Feedback control through cGMP-dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes. Circ. Res. 107, 1232\u20131240 (2010).","journal-title":"Circ. Res."},{"key":"8203_CR65","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1161\/CIRCRESAHA.114.302437","volume":"114","author":"KR G\u00f6tz","year":"2014","unstructured":"G\u00f6tz, K. R. et al. Transgenic mice for real-time visualization of cGMP in intact adult cardiomyocytes. Circ. Res. 114, 1235\u20131245 (2014).","journal-title":"Circ. Res."},{"key":"8203_CR66","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0065-230X(08)60765-4","volume":"74","author":"TS Lewis","year":"1998","unstructured":"Lewis, T. S., Shapiro, P. S. & Ahn, N. G. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74, 49\u2013139 (1998).","journal-title":"Adv. Cancer Res."},{"key":"8203_CR67","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1126\/science.1072682","volume":"298","author":"GL Johnson","year":"2002","unstructured":"Johnson, G. L. & Lapadat, R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, andp38 protein kinases. Science 298, 1911\u20131912 (2002).","journal-title":"Science"},{"key":"8203_CR68","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1152\/physrev.00054.2009","volume":"90","author":"BA Rose","year":"2010","unstructured":"Rose, B. A., Force, T. & Wang, Y. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol. Rev. 90, 1507\u20131546 (2010).","journal-title":"Physiol. Rev."},{"key":"8203_CR69","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1126\/science.281.5383.1668","volume":"281","author":"HJ Schaeffer","year":"1998","unstructured":"Schaeffer, H. J. et al. MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science 281, 1668\u20131671 (1998).","journal-title":"Science"},{"key":"8203_CR70","doi-asserted-by":"publisher","first-page":"6981","DOI":"10.1073\/pnas.0305894101","volume":"101","author":"T Vomastek","year":"2004","unstructured":"Vomastek, T. et al. Modular construction of a signaling scaffold: MORG1 interacts with components of the ERK cascade and links ERK signaling to specific agonists. Proc. Natl. Acad. Sci. USA 101, 6981\u20136986 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"8203_CR71","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1042\/BJ20040498","volume":"383","author":"K Takagaki","year":"2004","unstructured":"Takagaki, K. et al. Characterization of a novel lowmolecular-mass dual-specificity phosphatase-3 (LDP-3) that enhances activation of JNK and p38. Biochem. J. 383, 447\u201355 (2004).","journal-title":"Biochem. J."},{"key":"8203_CR72","doi-asserted-by":"publisher","first-page":"6983","DOI":"10.1128\/MCB.18.12.6983","volume":"18","author":"M Suhasini","year":"1998","unstructured":"Suhasini, M., Li, H., Lohmann, S. M., Boss, G. R. & Pilz, R. B. Cyclic-GMP-dependent protein kinase inhibits the Ras\/Mitogenactivated protein kinase pathway. Mol. Cell Biol. 18, 6983\u20136994 (1998).","journal-title":"Mol. Cell Biol."},{"key":"8203_CR73","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1161\/01.RES.85.3.238","volume":"85","author":"JJ Chiu","year":"1999","unstructured":"Chiu, J. J., Wung, B. S., Hsieh, H. J., Lo, L. W. & Wang, D. L. Nitric oxide regulates shear stress-induced early growth response-1. Expression via the extracellular signal-regulated kinase pathway in endothelial cells. Circ. Res. 85, 238\u2013246 (1999).","journal-title":"Circ. Res."},{"key":"8203_CR74","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1161\/hy0102.099025","volume":"39","author":"FM Martens","year":"2002","unstructured":"Martens, F. M. et al. Vessel-specific stimulation of protein synthesis by nitric oxide synthase inhibition: role of extracellular signal-regulated kinases 1\/2. Hypertension 39, 16\u201321 (2002).","journal-title":"Hypertension"},{"key":"8203_CR75","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/00005344-200309000-00004","volume":"42","author":"D Girardot","year":"2003","unstructured":"Girardot, D., Demeilliers, B., deBlois, D. & Moreau, P. ERK1\/2-mediated vasoconstriction normalizes wall stress in small mesenteric arteries during NOS inhibition in vivo. J. Cardiovasc. Pharmacol. 42, 339\u2013347 (2003).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"8203_CR76","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1074\/jbc.M304813200","volume":"279","author":"KW Raines","year":"2004","unstructured":"Raines, K. W. et al. Nitric oxide inhibition of ERK1\/2 activity in cells expressing neuronal nitric-oxide synthase. J. Biol. Chem. 279, 3933\u20133940 (2004).","journal-title":"J. Biol. Chem."},{"key":"8203_CR77","doi-asserted-by":"publisher","first-page":"H2072","DOI":"10.1152\/ajpheart.01097.2006","volume":"293","author":"A Bouallegue","year":"2007","unstructured":"Bouallegue, A., Daou, G. B. & Srivastava, A. K. Nitric oxide attenuates endothelin-1-induced activation of ERK1\/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway. Am. J. Physiol. Heart Circ. Physiol. 293, H2072\u2013H2079 (2007).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"8203_CR78","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ejphar.2010.09.053","volume":"658","author":"I Bhattacharya","year":"2011","unstructured":"Bhattacharya, I., Damjanovi\u0107, M., Dominguez, A. P. & Haas, E. Inhibition of activated ERK1\/2 and JNKs improves vascular function in mouse aortae in the absence of nitric oxide. Eur. J. Pharmacol. 658, 22\u201327 (2011).","journal-title":"Eur. J. Pharmacol."},{"key":"8203_CR79","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/FJC.0000000000000749","volume":"75","author":"RM Blanton","year":"2020","unstructured":"Blanton, R. M. cGMP Signaling and Modulation in Heart Failure. J. Cardiovasc. Pharmacol. 75, 385\u2013398 (2020).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"8203_CR80","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nature14332","volume":"519","author":"DI Lee","year":"2015","unstructured":"Lee, D. I. et al. Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease. Nature 519, 472\u2013476 (2015).","journal-title":"Nature"},{"key":"8203_CR81","doi-asserted-by":"publisher","first-page":"12925","DOI":"10.1073\/pnas.1414364111","volume":"111","author":"E Patrucco","year":"2014","unstructured":"Patrucco, E. et al. Roles of cGMP-dependent protein kinase I (cGKI) and PDE5 in the regulation of Ang II-induced cardiac hypertrophy and fibrosis. Proc. Natl. Acad. Sci. USA 111, 12925\u201312929 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"8203_CR82","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nrm1983","volume":"7","author":"J Heineke","year":"2006","unstructured":"Heineke, J. & Molkentin, J. D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev. Mol. Cell. Biol. 7, 589\u2013600 (2006).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"8203_CR83","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.1093\/emboj\/19.23.6341","volume":"19","author":"OF Bueno","year":"2000","unstructured":"Bueno, O. F. et al. The MEK1-ERK1\/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J. 19, 6341\u20136350 (2000).","journal-title":"EMBO J."},{"key":"8203_CR84","doi-asserted-by":"publisher","first-page":"14074","DOI":"10.1073\/pnas.0610906104","volume":"104","author":"NH Purcell","year":"2007","unstructured":"Purcell, N. H. et al. Genetic inhibition of cardiac ERK1\/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo. Proc. Natl. Acad. Sci. USA 104, 14074\u201314079 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"8203_CR85","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.yjmcc.2014.03.002","volume":"72","author":"S Ulm","year":"2014","unstructured":"Ulm, S. et al. Targeted deletion of ERK2 in cardiomyocytes attenuates hypertrophic response but provokes pathological stress induced cardiac dysfunction. J. Mol. Cell Cardiol. 72, 104\u2013116 (2014).","journal-title":"J. Mol. Cell Cardiol."},{"key":"8203_CR86","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nm.1893","volume":"15","author":"K Lorenz","year":"2009","unstructured":"Lorenz, K., Schmitt, J. P., Schmitteckert, E. M. & Lohse, M. J. A new type of ERK1\/2 autophosphorylation causes cardiac hypertrophy. Nat. Med. 15, 75\u201383 (2009).","journal-title":"Nat. Med."},{"key":"8203_CR87","doi-asserted-by":"publisher","first-page":"7440","DOI":"10.1073\/pnas.1221999110","volume":"110","author":"C Ruppert","year":"2013","unstructured":"Ruppert, C. et al. Interference with ERK(Thr188) phosphorylation impairs pathological but not physiological cardiac hypertrophy. Proc. Natl. Acad. Sci. USA 110, 7440\u20137445 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"8203_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15505-4","volume":"11","author":"A Tomasovic","year":"2020","unstructured":"Tomasovic, A. et al. Interference with ERKdimerization at the nucleocytosolic interface targets pathological ERK1\/2 signaling without cardiotoxic side-effects. Nat. Commun. 11, 1733 (2020).","journal-title":"Nat. Commun."},{"key":"8203_CR89","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1126\/science.286.5443.1374","volume":"286","author":"G Pages","year":"1999","unstructured":"Pages, G. et al. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science 286, 1374\u20131377 (1999).","journal-title":"Science"},{"key":"8203_CR90","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1046\/j.1365-2443.2003.00680.x","volume":"8","author":"N Hatano","year":"2003","unstructured":"Hatano, N. et al. Essential role for ERK2 mitogen-activated protein kinase in placental development. Genes Cells. 8, 847\u2013856 (2003).","journal-title":"Genes Cells."},{"key":"8203_CR91","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1074\/jbc.M506576200","volume":"281","author":"SK Shenoy","year":"2006","unstructured":"Shenoy, S. K. et al. beta-arrestin-dependent, G protein-independent ERK1\/2 activation by the beta2 adrenergic receptor. J. Biol. Chem. 281, 1261\u20131273 (2006).","journal-title":"J. Biol. Chem."},{"key":"8203_CR92","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/nprot.2016.136","volume":"11","author":"S Tyanova","year":"2016","unstructured":"Tyanova, S., Temu, T. & Cox, J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat. Protoc. 11, 2301\u20132319 (2016).","journal-title":"Nat. Protoc."},{"key":"8203_CR93","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1021\/acs.jproteome.5b00780","volume":"15","author":"C Bielow","year":"2016","unstructured":"Bielow, C., Mastrobuoni, G. & Kempa, S. Proteomics Quality Control: Quality Control Software for MaxQuant Results. J. Proteome. Res. 15, 777\u2013787 (2016).","journal-title":"J. Proteome. Res."},{"key":"8203_CR94","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. The Gene Ontology Consortium. Gene ontology: tool for the unification of biology. Nat. Genet. 25, 25\u201329 (2000).","journal-title":"Nat. Genet."},{"key":"8203_CR95","doi-asserted-by":"crossref","unstructured":"Kuleshov M. V., et al Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. gkw377 (2016).","DOI":"10.1093\/nar\/gkw377"},{"key":"8203_CR96","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","volume":"53","author":"Y Perez-Riverol","year":"2025","unstructured":"Perez-Riverol, Y. et al. The PRIDE database at 20 years: 2025 update. Nucleic Acids Res. 53, D543\u2013D553 (2025).","journal-title":"Nucleic Acids Res."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08203-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08203-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08203-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T20:02:21Z","timestamp":1748376141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08203-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8203"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-08203-8","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"assertion":[{"value":"5 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"817"}}